CaseVuCategory Archives: Press Releases
Precipio Launches HemeScreen® Anemia Panel, A One-Of-Its-Kind Testing Tool
Laboratories can use this rapid, cost effective test to distinguish malignancy-driven anemia from other causes [...]
Jun
Precipio Announces Q1-2021 And Year-End Shareholder Update Call
Conference Call to be held on Thursday, May 20th, 2021 at 5:00 PM EST NEW [...]
May
Precipio Launches New HemeScreen Panel For AML, With An Unparalleled 4-Hour Turnaround-Time
Physician Office Laboratory (POL) Customers will be able to immediately integrate this important test into [...]
May
Precipio Launches Its Rapid COVID-19 Antibody Test On Amazon Platform
Nirmidas’ test is available to POC healthcare providers with an Amazon business account NEW HAVEN, [...]
May
Current Signed Customers Expected To Generate $1M Annualized Reported Revenues From Precipio’s HemeScreen POL Offering By Q4-2021
Precipio reaffirms forecast that product revenues will reach approximately 50% of pathology revenue by the [...]
Apr
Precipio Enters Into An At-The -Market (ATM) Financing Arrangement
NEW HAVEN, CT, (April 5th, 2021) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces a new [...]
Apr
Precipio Announces 95% Annual Growth YoY And 180% Quarterly Growth YoY
HemeScreen projected to rapidly become a material revenue contributor in 2021 NEW HAVEN, CT, (March [...]
Mar
Precipio Announces Q4-2020 And Year-End Shareholder Update Call
Conference Call to be held on Wednesday, March 31st, 2021 at 5:00 PM EST NEW [...]
Mar
Mr. Ron Andrews Joins Precipio’s Board Of Directors
Company Strengthens Depth of Expertise in Products Industry NEW HAVEN, CT, (March 3rd, 2021) – Specialty [...]
Mar
Mr. Richard Sandberg Is Appointed Chairman Of Precipio’s Board Of Directors
NEW HAVEN, CT, (March 3rd, 2021) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces the appointment of [...]
Mar